Tiziana Life Sciences has shared positive three-month neuroimaging scores in non-active secondary progressive multiple sclerosis (na-SPMS) patients receiving intranasal foralumab. Affecting ...

UCB’s Bimzelx (bimekizumab) has been approved by the European Commission (EC) to treat active moderate-to-severe hidradenitis ...

Johnson & Johnson’s (J&J) Rybrevant (amivantamab) in combination with chemotherapy, has been recommended by the European ...

The World Health Organization (WHO) has prequalified a new inactivated and simplified oral vaccine for cholera, Euvichol-S, ...

Incyte has entered into a $750m definitive agreement to acquire Escient Pharmaceuticals and its pipeline of small molecule ...

Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration aimed at developing CRISPR-based gene ...

Afon Technology has been presented with Junkosha’s Technology Innovator of the Year Award, along with a $25,000 prize, for ...

Fox&Cat has relaunched today with its new people-first, senior consultant operating model and bespoke planning framework, ...

PME speaks to Lorna Pender, Global Patient Engagement Lead at Clinigen, about the treatment options available to patients ...

Currently, the life sciences industry is under huge pressure. Right now the global pharmaceutical market has experienced ...

The National Institute for Health and Care Excellence (NICE) has recommended Menarini Stemline UK’s Nexpovio (selinexor) as ...

Takeda has announced that its subcutaneous (SC) Entyvio (vedolizumab) has been approved by the US Food and Drug ...